ALDOA's Role in Colorectal Cancer
Author Information
Author(s): Sun Liang, Lu Ting, Jiang Linhua, Yao Huihui, Xu Qixuan, Sun Jie, Yang Xiaoqin, He Songbing, Zhu Xinguo
Primary Institution: The First Affiliated Hospital of Soochow University, Suzhou, China
Hypothesis
The study aimed to investigate the role of ALDOA in the initiation and development of colorectal cancer (CRC).
Conclusion
ALDOA is identified as a new metabolic regulator of YAP that suppresses AMPK signaling, suggesting a novel avenue for treating CRC.
Supporting Evidence
- ALDOA expression was significantly higher in CRC tissues compared to normal tissues.
- High ALDOA levels correlated with poor prognosis in CRC patients with stages I-III.
- ALDOA promoted CRC cell proliferation and migration in vitro and in vivo.
Takeaway
ALDOA helps cancer cells grow and spread by changing how they use energy, which could be a new target for treating colorectal cancer.
Methodology
The study involved analyzing ALDOA expression in CRC tissues, performing loss and gain of function experiments, and using Kaplan-Meier analysis for survival correlation.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website